Literature DB >> 28653025

Proteomics data on MAP Kinase Kinase 3 knock out bone marrow derived macrophages exposed to cigarette smoke extract.

Roshni Srivastava1, Praveen Mannam1, Navin Rauniyar2, TuKiet T Lam2, Ruiyan Luo3, Patty J Lee1, Anup Srivastava4.   

Abstract

This data article reports changes in the phosphoproteome and total proteome of cigarette smoke extract (CSE) exposed WT and MAP Kinase Kinase 3 knock out (MKK3-/-) bone marrow derived macrophages (BMDM). The dataset generated is helpful for understanding the mechanism of CSE induced inflammation and the role of MAP kinase signaling pathway. The cellular proteins were labeled with isobaric tags for relative and absolute quantitation (iTRAQ®) reagents and analyzed by LC-MS/MS. The standard workflow module for iTRAQ® quantification within the Proteome Discoverer was utilized for the data analysis. Ingenuity Pathway Analysis (IPA) software and Reactome was used to identify enriched canonical pathways and molecular networks (Mannam et al., 2016) [1]. All the associated mass spectrometry data has been deposited in the Yale Protein Expression Database (YPED) with the web-link to the data: http://yped.med.yale.edu/repository/ViewSeriesMenu.do;jsessionid=6A5CB07543D8B529FAE8C3FCFE29471D?series_id=5044&series_name=MMK3+Deletion+in+MEFs.

Entities:  

Keywords:  Cigarette smoke; Inflammation; MKK3; Proteomics; iTRAQ®

Year:  2017        PMID: 28653025      PMCID: PMC5476452          DOI: 10.1016/j.dib.2017.05.049

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table

Value of the data

Proteomic characterization of the effect of MKK3 deletion in bone marrow derived macrophages (BMDM), which provides data on MAP kinase signaling targets [2], [3], [4], [5], [6], [7]. The BMDM proteomics data (total and phospho) has been presented which can be used as a reference for other inflammatory signaling molecules in MAP kinase pathway. The major canonical pathways affected after cigarette smoke in WT and MKK3 deleted BMDM are presented and can be utilized to interrogate the role of MAP kinases in other signaling schemes in cigarette smoke induced injury.

Data

In this paper, we provide proteomics data generated before and after cigarette smoke extract (CSE) exposed BMDM isolated from MKK3−/− and WT mice. The workflow is presented as Fig. 1. The data was analyzed using REACTOME, pathway search engine. The iTRAQ® quantitative proteomics data of MKK3−/−/WT BMDM at baseline showed enrichment of many canonical pathways, presented in Table 1. The comparison of WT and MKK3−/− BMDM responses after CSE is presented in Table 2. Using QIAGEN׳s Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City) the analysis of the data reflects changes in the molecules upregulated by MKK3 with the threshold criteria of at least 4 proteins affected (Table 3).
Fig. 1

The workflow scheme of iTRAQ® data generation.

Table 1

Affected pathways in MKK3−/− BMDM.

#Pathway name#Entities foundEntities ratioEntities pValueEntities FDR#Reactions found
1Neutrophil degranulation570.0458627941.27E−131.63E−1010
2L13a-mediated translational silencing of Ceruloplasmin expression230.0107013192.51E−101.07E−073
3GTP hydrolysis and joining of the 60S ribosomal subunit240.0107968666.64E−101.71E−073
4Formation of a pool of free 40S subunits210.0097458441.75E−093.21E−072
5Cap-dependent Translation Initiation240.0114656987.56E−099.83E−0718
6Eukaryotic Translation Initiation240.0114656988.48E−099.83E−0721
7Ribosomal scanning and start codon recognition150.0056373023.30E−083.23E−062
8Formation of the ternary complex, and subsequently, the 43S complex130.0049684691.87E−071.59E−053
9Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex180.0091725594.07E−073.26E−051
10Translation260.0150965034.97E−073.53E−0535

The proteomic data at baseline conditions was utilized to generate affected pathways using REACTOME. The data is generated from 3 biological replicates.

Table 2

Affected pathways in MKK3−/− BMDM after cigarette smoke exposure (CSE).

#Pathway name#Entities foundEntities ratioEntities p ValueEntities FDR#Reactions found
1Neutrophil degranulation210.0458627941.47E−060.0012913219
2Glucose metabolism70.0077393462.59E−040.11383790713
3Glycogen breakdown (glycogenolysis)30.0014332120.0010542910.2051818247
4Glycolysis40.0032486150.0010925180.2051818244
5Ribosomal scanning and start codon recognition50.0056373020.0014053550.2051818242
6Sphingolipid metabolism70.0085037260.0019331180.241639715
7Activation of the mRNA upon binding of the cap-binding complex and eIFs50.0057328490.0038567280.2895422914
8Translation initiation complex formation50.0056373020.0046246030.2895422912
9Translation80.0150965030.0049853890.28954229129
10Formation of the ternary complex, and subsequently, the 43S complex40.0049684690.0049921080.2895422911

The proteomic data from MKK3−/− over WT BMDM after CSE exposure was compared to generate affected pathways using REACTOME. The data is generated from 3 biological replicates.

Table 3

List of top affected molecules in MKK3−/− BMDM.

MKK3-/-/WT: ControlMKK3-/-/WT: CSE
HighCharged Multivesicular Body Protein 3HighEukaryotic translation initiation factor 4B
Glyoxalase ICytochrome c oxidase subunit 4I1
Annexin A6GDP-mannose pyrophosphorylase B
N-Terminal Xaa-Pro-Lys N-Methyltransferase 1Ubiquitin fusion degradation protein UFD1
CeruloplasminReticulocalbin 2
LowSPRY domain containing 7LowGolgi transport 1B
S100 Calcium Binding Protein A8Capping actin protein of muscle Z-line beta subunit
Growth Factor Independent 1 Transcriptional RepressorThioredoxin like 1
Dihydrolipoamide Branched Chain Transacylase E2Complement component 3
Hematopoietic Prostaglandin D SynthaseLeucine-tRNA ligase

The most affected proteins, increased or decreased, in MKK3−/− BMDM with and without CSE exposure were analyzed by IPA software. Benjamin-Hochberg Multiple testing correction was applied for the analysis. The data is generated from 3 biological replicates.

The workflow scheme of iTRAQ® data generation. Affected pathways in MKK3−/− BMDM. The proteomic data at baseline conditions was utilized to generate affected pathways using REACTOME. The data is generated from 3 biological replicates. Affected pathways in MKK3−/− BMDM after cigarette smoke exposure (CSE). The proteomic data from MKK3−/− over WT BMDM after CSE exposure was compared to generate affected pathways using REACTOME. The data is generated from 3 biological replicates. List of top affected molecules in MKK3−/− BMDM. The most affected proteins, increased or decreased, in MKK3−/− BMDM with and without CSE exposure were analyzed by IPA software. Benjamin-Hochberg Multiple testing correction was applied for the analysis. The data is generated from 3 biological replicates.

Experimental design, materials and methods

Sample preparation and iTRAQ® labeling

Cell pellets were lysed (using short 15 s sonication burst) in a RIPA buffer spiked with protease and phosphatase inhibitors. The lysates were centrifuged at 14,000 rpm for 20 min, supernatants were collected, and proteins were precipitated using chloroform:methanol:water precipitation method. The samples, three biological replicates each of the control and CSE-treated (3% vol/vol, 24 h) sample, were further processed and labeled with iTRAQ® reagents according to manufacturer׳s instructions (Sciex, Framingham, MA). Briefly, protein pellets were resuspended in 0.5 M TEAB/0.1% Rapigest buffer, reduced, alkylated, and digested with trypsin by incubating overnight at 37 °C. Protein concentration of the samples were measured by amino acid analysis of tryptic digests using Hitachi L-8900 Amino Acid Analyzer. Equal amount (15 µg) of peptides were labeled with iTRAQ® reagents, combined, desalted using MacroSpin column (The Nest Group, Inc., Southboro, MA), and dried down in a SpeedVac concentrator. Desalted labeled peptides were subsequently subjected to phosphopeptide enrichment using titanium dioxide (TiO2) resin (Glygen Corporation, Columbia, MD). The speed-vac dried flowthrough and phosphopeptide-enriched elution fractions were resuspended in buffer A (0.1% formic acid in water), and subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis.

Mass spectrometry data acquisition and analysis

The samples were analyzed by LC-MS/MS on a Q Exactive Plus mass spectrometer (Thermo Scientific, San Jose, CA) interfaced with nanoACQUITY UPLC System (Waters, Milford, MA) at the front end. Samples were loaded into a trapping column (nanoACQUITY UPLC Symmetry C18 Trap Column, 180 µm×20 mm, Product Number: 186006527) at a flowrate of 5 µl/min and separated with a C18 column (nanoACQUITY column Peptide BEH C18, 75 µm×250 mm, Product number: 186003545). The peptides were eluted with buffer B (0.1% formic acid in acetonitrile) gradient from 5 to 30% in 140 min at a flowrate of 300 nL/min. LC-MS/MS data were acquired using Top-20 data-dependent acquisition method. Full-scan MS spectra (m/z range 300–1700) were acquired with a resolution of 70,000, automatic gain control (AGC) target of 3e6, and a maximum injection time of 45 ms. MS/MS scans were acquired with a resolution of 17,500, AGC target of 1e5, and maximum injection time of 100 ms. The precursor ions were selected with an isolation window of 1.2 m/z and fragmented by higher collision energy dissociation (HCD) with normalized collision energies stepped to 28 and 30. Dynamic exclusion was set to 45 s to keep the repeat sequencing of peptides to minimum. Peptides and proteins were identified and quantified with Sequest HT search engine using Proteome Discoverer v2.0 (Thermo Scientific) software. A standardized iTRAQ® 8plex quantification workflow module within the Proteome Discoverer was slightly modified as below and utilized for the analysis. MS/MS data were searched against the mouse SwissProt database (downloaded in September 2015; number of protein entries=16,719). The search parameters include 10 ppm precursor mass tolerance, 0.6 Da fragment mass tolerance, and trypsin miscleavage setting of two. Static modification settings included carbamidomethylation (+57.021 Da) on cysteine and iTRAQ® 8plex (304.205 Da) on N-terminus and lysine, while dynamic modifications were set to include oxidation (+15.995 Da) on methionine and phosphorylation (+79.966 Da) on serine, threonine, and tyrosine. Peptide spectrum matches (PSMs) were verified based on q-values set to 1% false discovery rate (FDR) using the Percolator module. Reporter Ions Quantifier node was used in the processing step workflow, and the Peptide and Protein Quantifier node was used in the consensus workflow of the Proteome Discoverer v2.0 to calculate and quantify peptides and protein abundances and ratios across samples.

Functional annotation chart preparation

Protein with log fold change list was loaded on the IPA platform with a mouse background. The protein list was analyzed by functional annotation tool and affected pathways were analyzed. The search criteria included a minimum of 5 count and EASE score of 0.01 (Table 1).

Canonical pathway identification

The protein data was uploaded on IPA and REACTOME and pathway analysis was performed. The reference set was the inbuilt knowledge base, all data sources were included for analysis such as protein-protein ineteractions and microRNA-mRNA interactions. Only those relationships were considered where confidence was equal to experimentally observed relationships. Stringent criteria was applied for filetring the results. B-H multiple testing correction p-value scoring method was used and values greater than 3 with a threshold value of 0.05 are displayed.
Subject areaCell Biology and Kinase signaling
More specific subject areaMAP kinase signaling
Type of dataTable and workflow
How data was acquiredLC-MS/MS on a Q Exactive Plus mass spectrometer (ThermoFisher Scientific, San Jose, CA) interfaced with a nanoACQUITY UPLC System (Waters, Milford, MA)
Data formatThe standard workflow module for iTRAQ(R) 8-plex quantification within the Proteome Discoverer was utilized for the analysis. Peptide spectrum matches (PSMs) were verified based on q-values set to 1% false discovery rate (FDR) using the Percolator module
Experimental factorsEffect of cigarette smoke on the proteome of mouse bone marrow derived macrophages and effect of MKK3 deletion
Experimental featuresBaseline difference in MKK3 knockout and wild-type mouse bone marrow derived macrophages and their response to cigarette smoke
Data source locationNew Haven, CT, USA.
Data accessibilityData available within this article and athttp://yped.med.yale.edu/repository/ViewSeriesMenu.do;jsessionid=6A5CB07543D8B529FAE8C3FCFE29471D?series_id=5044&series_name=MMK3+Deletion+in+MEFs
  7 in total

Review 1.  MAP kinase-dependent pathways in cell cycle control.

Authors:  S L Pelech; D L Charest
Journal:  Prog Cell Cycle Res       Date:  1995

2.  Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury.

Authors:  Praveen Mannam; Xuchen Zhang; Peiying Shan; Yi Zhang; Amanda S Shinn; Yitao Zhang; Patty J Lee
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

3.  MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.

Authors:  Carlos Rossa; Kathryn Ehmann; Min Liu; Chetan Patil; Keith L Kirkwood
Journal:  J Interferon Cytokine Res       Date:  2006-10       Impact factor: 2.607

4.  MKK3 mediates inflammatory response through modulation of mitochondrial function.

Authors:  Anup Srivastava; Amanda S Shinn; Patty J Lee; Praveen Mannam
Journal:  Free Radic Biol Med       Date:  2015-02-17       Impact factor: 7.376

5.  MKK3 deletion improves mitochondrial quality.

Authors:  Anup Srivastava; John McGinniss; Yao Wong; Amanda S Shinn; TuKiet T Lam; Patty J Lee; Praveen Mannam
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

6.  MKK3 influences mitophagy and is involved in cigarette smoke-induced inflammation.

Authors:  Praveen Mannam; Navin Rauniyar; TuKiet T Lam; Ruiyan Luo; Patty J Lee; Anup Srivastava
Journal:  Free Radic Biol Med       Date:  2016-10-04       Impact factor: 7.376

7.  SILAC based protein profiling data of MKK3 knockout mouse embryonic fibroblasts.

Authors:  Anup Srivastava; Amanda S Shinn; TuKiet T Lam; Patty J Lee; Praveen Mannam
Journal:  Data Brief       Date:  2016-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.